Jump to section
Section 1
Price Regulation on the Retail and Wholesale of Drugs and—Medicines
Section 1.
Price Regulation on the Retail and Wholesale of Drugs and—Medicines.
—The price regulation through MRP and/or MWP under EO No. 104 shall be imposed on the 34 drug molecules or 71 drug formulas indicated in Annex A of this Order.
Section 2
Labelling Requirement for MRP Drugs and Medicines
Section 2.
Labelling Requirement for MRP Drugs and Medicines.
—Every manufacturer, importer, distributor, wholesaler, trader or retailer of a drug/medicine intended for sale shall display the retail price which shall not exceed the MRP. The MRP, preceded by the words "RETAIL PRICE NOT TO EXCEED," and "UNDER DRUG PRICE REGULATION," on a red strip, shall be clearly printed on the label of the immediate container of the drug and medicine and the minimum pack thereof offered for retail. The labelling shall also be applied to drug formulas or medicines under MRP through EO No. 104.
Section 3
Review
Section 3.
Review.
—The list of medicines and their corresponding MRPs and/or MWPs, and those covered by EO No. 104, shall be subject to the review of the DOH, in consultation with the DTI, six (6) months after the effectivity of this Order, and every 6 months thereafter.
Section 4
Measures to Improve Access to Medicines
Section 4.
Measures to Improve Access to Medicines.
—The DOH, in consultation with relevant government agencies, including the DTI and the Philippine Competition Commission, is hereby directed to study and propose measures, including, but not limited to pooled procurement, price negotiation and other mechanisms, which will influence the supply, demand and expenditure on drugs and medicines, in accordance with RA No. 9502, and other relevant laws and regulations.
Section 5
Implementing Guidelines
Section 5.
Implementing Guidelines.
—As may be necessary, the DOH shall formulate guidelines for the effective implementation of this Order.
Section 6
Agency Support
Section 6.
Agency Support.
—The Presidential Communications Operations Office is hereby directed to provide the necessary support and assistance to the DOH for the dissemination of information relative to this Order.
All other government agencies and instrumentalities including government- owned or-controlled corporations, government financial institutions and state colleges and universities, are hereby directed to provide the necessary support to the DOH in the information dissemination, enforcement and implementation of this Order.
Section 7
Violations
Section 7.
Violations.
—Any violation of this Order shall be dealt with in accordance with RA No. 9502, and other related laws. Pursuant to Section 19 of RA No. 9502, the Secretary of Health is directed to investigate alleged violations of the MRP and/or MWP under this Order, impose administrative fines and penalties, and call upon and deputize government entities for assistance necessary to carry out the purpose of this Order.
Section 8
Transition
Section 8.
Transition.
—Within a non-extendable period of ninety (90) days from the effectivity of this Order, existing inventory stock shall be disposed of at prevailing prices. Thereafter, regardless of the status of the existing stock, the MRP and/or MWP under this Order shall be strictly implemented.
Section 9
Separability
Section 9.
Separability.
If—any part or provision of this Order shall be held unconstitutional or invalid, the other parts not affected thereby shall continue to be in full force and effect.
Section 10
Repeal
Section 10.
Repeal.
—EO No. 821 (s. 2009) is hereby repealed. All executive issuances, orders, rules and regulations or parts thereof inconsistent with this Order are hereby revoked or modified accordingly.
Section 11
Effectivity
Section 11.
Effectivity.
—This Order shall take effect upon its publication in the Official Gazette or in a newspaper of genera! circulation.
DONE,
—in the City of Manila, this 7th day of December in the Year of Our Lord, Two Thousand and Twenty-One.
(SGD.)—
RODRIGO ROA DUTERTE
By the President:
(SGD.)—
SALVADOR C. MEDIALDEA
Executive Secretary